NCT06664021
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- No.2 People's Hospital of Fuyang city Fuyang, Anhui, China
- Anhui province hospital Hefei, Anhui, China
Clinical trial condition
Cholangiocarcinoma
Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
490 public trials
154 recruiting studies
Cholangiocarcinoma trial results
NCT06721286
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
NCT06720883
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
- Locations
-
- Azienda Ospedaliera di Padova Padova, Italy
Recruiting
Spanish Registry of Digestive Tumours RETUD
NCT06711211
- Conditions
- Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +30 more
- Locations
-
- Grupo de Tratamiento de los Tumores Digestivos (TTD) Madrid, Spain
NCT05321992
- Conditions
- Adenocarcinoma, Adherence Interventions, Behavior, +17 more
- Locations
-
- Khon Kaen University Phu Wiang, Changwat Khon Kaen, Thailand
NCT06341764
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
- Locations
-
- Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale Naples, Italia, Italy
- Ospedale Cardarelli, Napoli Naples, Italia, Italy
- Università di Napoli "Federico II", Napoli Naples, Italia, Italy
- Ospedale san Camillo Forlanini/Spallanzani, Roma Roma, Italia, Italy
NCT06160752
- Conditions
- Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +24 more
- Locations
-
- University of California San Francisco (UCSF) San Francisco, California, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- The Ohio State University Columbus, Ohio, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
Recruiting
GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC
NCT06505486
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, China
NCT06487663
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China